22nd Century Group, Inc. (XXII )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol XXII
- Company 22nd Century Group, Inc.
- Price $3.93
- Changes Percentage -18.97
- Change -0.92
- Day Low $3.89
- Day High $4.74
- Year High $263.93
- Year Low $0.48
- Market Cap $82,121
- Price Avg 50 EMA (D) $1.53
- Price Avg 200 EMA (D) $12.59
- Exchange NASDAQ
- Volume 309,482
- Average Volume 1,350,508
- Open $4.66
- Previous Close $4.85
- EPS 532.5
- PE 0.00
- Earnings Announcement 2026-08-19 12:00:00
- Shares Outstanding $166,912
Company brief: 22ND CENTURY GROUP, INC. (XXII )
- Consumer Defensive
- Tobacco
- Mr. Lawrence D. Firestone
- https://www.xxiicentury.com
- US
- N/A
- 01-26-2011
- US90137F2020
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.